Pulmonary edema for md exam answer 10 marks from fishman and Murray only

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I have very rich content from both textbooks. I now have enough for a comprehensive 10-mark answer. Let me compose the answer.

Pulmonary Edema

(10-Mark Answer from Fishman's and Murray & Nadel's)

Definition

Pulmonary edema is defined as excessive extravascular water in the lungs resulting when fluid is filtered from the pulmonary circulation into the extravascular compartments faster than it can be removed. Accumulation of this fluid has serious consequences on gas exchange because efficient gas exchange cannot occur in fluid-filled alveoli.

Murray & Nadel's Textbook of Respiratory Medicine, Chapter 133
Fishman's Pulmonary Diseases and Disorders, Chapter 140

Pathophysiology - The Starling Equation

The forces governing fluid exchange across the pulmonary microvascular barrier are expressed in the Starling equation:

Jv = LpS[(Pc - Pi) - σd(πc - πi)]

Where:

Jv = net fluid-filtration rate across the microvascular barrier
Lp = hydraulic conductivity (permeability) of the microvascular barrier
S = surface area of the barrier
Pc = pulmonary capillary (microvascular) hydrostatic pressure
Pi = interstitial (perimicrovascular) hydrostatic pressure
πc = capillary plasma colloid osmotic (oncotic) pressure
πi = interstitial fluid osmotic pressure
σd = average osmotic reflection coefficient of the barrier

In health, lung lymph flow (which reflects microvascular fluid crossing) is normally less than 0.01% of total lung blood flow. Microvascular hydrostatic pressure is the principal force causing filtration - the pumping action of the heart drives this steady state.

Murray & Nadel's, p. 3109-3110
Fishman's, p. (block 29)

Classification

The Starling equation predicts two fundamentally different types of pulmonary edema:

1. Increased Pressure (Hydrostatic/Cardiogenic) Edema

Occurs when the net driving forces increase, forcing fluid across the barrier at a rate exceeding lymphatic removal. Common causes include:

Left heart failure - As the heart fails, compensatory increases in vascular volumes (Frank-Starling mechanism) raise preload of the left ventricle, increasing pulmonary capillary wedge pressure (PCWP). When PCWP rises above 18-20 mmHg, fluid floods into the interstitium and eventually the alveoli.
Mitral stenosis - obstruction to left atrial outflow raises pulmonary venous and capillary pressures
Volume overload - excess intravenous fluids, renal failure
Postobstructive pulmonary edema - high negative intrathoracic pressures during upper airway obstruction (laryngospasm, epiglottitis, croup) are transmitted to the interstitium, lowering interstitial hydrostatic pressure and pulling fluid out. Mechanical effects also increase cardiac preload, afterload, and pulmonary blood flow.
Decreased oncotic pressure - hypoalbuminemia (cirrhosis, nephrotic syndrome, malnutrition, pregnancy) lowers the osmotic pressure gradient opposing filtration; edema accumulates at lower hydrostatic pressures
Reexpansion pulmonary edema - after thoracentesis with lung re-expansion

The edema fluid in increased pressure edema has a low protein concentration relative to plasma (protein ratio < 0.6), because the intact barrier restricts protein passage.

2. Increased Permeability (Noncardiogenic) Edema

Occurs when the normal barriers to fluid filtration are damaged by injury. The conductance of both liquid and protein is allowed through paracellular pathways. This is the hallmark of Acute Respiratory Distress Syndrome (ARDS).

Causes (direct and indirect lung injury):

Direct: pneumonia, aspiration, pulmonary contusion, near-drowning, toxic inhalation
Indirect: sepsis, trauma, transfusion-associated lung injury (TRALI), pancreatitis, drug overdose

The edema fluid in increased permeability edema has a high protein concentration (protein ratio > 0.75), because the damaged barrier cannot restrict protein.

3. Mixed/Lymphatic Impairment Edema (rare)

Impaired lymphatic drainage of filtered fluid can contribute to edema but is a very rare primary cause.

Murray & Nadel's, p. 3109-3115
Fishman's, Chapter 140

Sequence of Fluid Accumulation

Edema accumulates in a predictable sequence:

Interstitial phase: Fluid first accumulates in the loose perivascular and peribronchial connective tissue (low-pressure interstitial sump). The alveolar walls remain dry. Lymph flow increases 2-3 fold to compensate.
Alveolar flooding phase: Once interstitial capacity is overwhelmed, fluid crosses the alveolar epithelium and floods the alveoli. This is the symptomatic phase with rapid deterioration in gas exchange.

Clinical Features

Symptoms

Dyspnea (earliest and most prominent), especially orthopnea and paroxysmal nocturnal dyspnea in cardiogenic edema
Cough, often productive of frothy, pink-tinged sputum
Anxiety, diaphoresis in acute severe episodes

Signs

Tachypnea, use of accessory muscles
Fine bilateral inspiratory crackles (crepitations) at lung bases, progressing upward
Wheeze ("cardiac asthma")
S3 gallop, elevated JVP, peripheral edema in cardiogenic causes
Cyanosis in severe hypoxemia
Murray & Nadel's, p. 3115-3117

Diagnostic Studies

Chest Imaging

Interstitial edema (early): peribronchial cuffing, Kerley B lines (horizontal lines at the lung periphery, reflecting distended interlobular lymphatics), loss of vascular definition, hilar haziness
Alveolar edema (advanced): bilateral patchy/confluent air-space opacities, often in a bat-wing or perihilar distribution
In cardiogenic edema: cardiomegaly, upper lobe vascular diversion, pleural effusions
In ARDS (permeability edema): bilateral opacities without cardiomegaly or pleural effusions, normal or reduced heart size

Arterial Blood Gas

Hypoxemia (low PaO2), initially with hypocapnia from hyperventilation
In severe cases: hypercapnia and respiratory acidosis

Differentiation of Cardiogenic vs. Permeability Edema

A key clinical tool is edema fluid protein concentration:

Edema fluid / plasma protein ratio: < 0.6 = increased pressure edema; > 0.75 = increased permeability edema
PCWP: elevated (> 18 mmHg) in cardiogenic edema; normal (< 18 mmHg) in ARDS/permeability edema
BNP/NT-proBNP: elevated in cardiogenic causes
Murray & Nadel's, p. 3117-3120

Treatment

Emergency Therapy (both types)

Supplemental oxygen, target SpO2 > 94%
Non-invasive positive pressure ventilation (NIPPV/CPAP/BiPAP): improves oxygenation rapidly, reduces work of breathing, decreases need for intubation
Endotracheal intubation and mechanical ventilation if severe

Increased Pressure (Cardiogenic) Edema

Diuretics: IV furosemide - reduces preload by promoting venous dilatation (within minutes) and diuresis; first-line therapy
Vasodilators: IV nitroglycerin and sodium nitroprusside reduce preload and afterload, rapidly lowering PCWP
Morphine: reduces anxiety, provides venodilatation, decreases preload (use with caution)
Inotropes: dobutamine or dopamine in cardiogenic shock with low cardiac output
Position: sit patient upright
Treat underlying cause (arrhythmia, ACS, hypertensive emergency)

Increased Permeability (ARDS) Edema

Lung-protective mechanical ventilation: low tidal volume (6 mL/kg predicted body weight), limiting plateau pressure < 30 cmH2O - the cornerstone of ARDS management
Conservative fluid management: once hemodynamically stable, negative fluid balance reduces edema
Prone positioning: for moderate-severe ARDS (PaO2/FiO2 < 150)
Neuromuscular blockade: for severe ARDS in first 48 hours
Corticosteroids: for certain causes (organizing ARDS, COVID-19)
No proven specific pharmacotherapy for the barrier injury
Murray & Nadel's, p. 3120-3130
Fishman's, Chapter 141

Resolution of Pulmonary Edema

Resolution requires:

Active sodium transport by alveolar epithelial cells (type II pneumocytes) drives osmotic removal of water from alveoli
Aquaporin water channels (especially AQP5 on type I pneumocytes) facilitate water movement
Lymphatic drainage clears interstitial fluid
Protein clearance: by transcytosis and macrophage phagocytosis

In increased pressure edema, resolution is rapid once filling pressures are lowered. In permeability edema (ARDS), resolution is slower and depends on recovery of the epithelial barrier; poor epithelial repair portends worse outcomes.

Murray & Nadel's, p. 3130-3132

Key Points Summary

Feature	Cardiogenic (Increased Pressure)	Non-cardiogenic (Increased Permeability)
Mechanism	Elevated PCWP / hydrostatic forces	Damaged endothelial/epithelial barrier
Edema fluid protein ratio	< 0.6	> 0.75
PCWP	> 18 mmHg	< 18 mmHg
BNP	Elevated	Normal/mildly elevated
CXR	Cardiomegaly, Kerley B lines, effusions	Bilateral opacities, no cardiomegaly
Main treatment	Diuretics, vasodilators, NIPPV	Lung-protective ventilation, conservative fluids
Resolution	Rapid with preload reduction	Slow (days-weeks)

Sources:

Murray & Nadel's Textbook of Respiratory Medicine, 7th ed. - Chapter 133 (Pulmonary Edema) and Chapter 134 (ARDS)
Fishman's Pulmonary Diseases and Disorders, 5th ed. - Chapter 140 (ARDS Pathogenesis) and related chapters

This is a shared conversation. Sign in to Orris to start your own chat.